Bixiye
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2081 - 2090 ee natiijooyinka 3167
Bixiye
QP77-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective December 1, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP78-21 Commercial Pharmacy Benefit Update – New Drug-Related Quantity Limit (QL) Criteria: Stromectol® (ivermectin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP79-21 New Availity Appeal Portal Available to Create, Submit and Inquire on Post Service Claim Appeals
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
P54-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P56-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective December 6, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P55-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization and Claims Submission for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P53-21 Update for New-to-Market Medical Drug: aducanumab (Aduhelm)
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
2021 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P58-21 2022 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021